Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

C/EBPβ regulates the JAK/STAT signaling pathway in triple‐negative breast cancer

4 Mar 2021

Abstract excerpt

C/EBPβ is a member of the CCAAT/enhancer-binding protein (C/EBP) family, which consists of a number of b-ZIP transcription factors. Although C/EBPβ has been implicated in the development of certain cancers, including breast cancer, it remains unknown whether dysregulation of C/EBPβ in breast cancer is subtype-specific. Moreover, the underlying mechanisms by which C/EBPβ regulates breast cancer carcinogenesis are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Cytokine Signaling Pathways and Interactions
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33660927
DOI: 10.1002/2211-5463.13138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

C/EBPβ regulates the JAK/STAT signaling pathway in triple‐negative breast cancerPMID 33660927Read ↗

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast CancerSemantic proximity Read ↗

C/EBPɑ is crucial determinant of epithelial maintenance by preventing epithelial-to-mesenchymal transitionSemantic proximity Read ↗

Dysregulation of Transcription Factor EB Contributes to Cell Proliferation, Metastasis and Stemness in Breast CancerSemantic proximity Read ↗

The Many Faces of C/EBPδ and their Relevance for Inflammation and CancerSemantic proximity Read ↗

BET inhibitors as novel therapeutic agents in breast cancerSemantic proximity Read ↗

Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast CancerSemantic proximity Read ↗

Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an updateSemantic proximity Read ↗

Thyroid Hormone Receptor Beta as Tumor Suppressor: Untapped Potential in Treatment and Diagnostics in Solid TumorsSemantic proximity Read ↗

Molecular Profiling of Inflammatory Breast CancerSemantic proximity Read ↗

C/EBPβ isoform-specific regulation of migration and invasion in triple-negative breast cancer cellsSemantic proximity Read ↗

Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activitySemantic proximity Read ↗

Research Resource: Global Identification of Estrogen Receptor β Target Genes in Triple Negative Breast Cancer CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.